Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apomorphine
Apomorphine hydrochloride 5mg/mL
Solution for infusion
Max Health Limited
Apotek Produktion & Laboratorier AB, Umea, Sweden

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ranexa
Ranolazine 375mg
Modified release tablet
Pharmacy Retailing (NZ) Limited trading as Healthcare Logistics
Menarini - Von Heyden GmbH, Dresden, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ranexa
Ranolazine 500mg
Modified release tablet
Pharmacy Retailing (NZ) Limited trading as Healthcare Logistics
Menarini - Von Heyden GmbH, Dresden, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ranexa
Ranolazine 750mg
Modified release tablet
Pharmacy Retailing (NZ) Limited trading as Healthcare Logistics
Menarini - Von Heyden GmbH, Dresden, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Revlimid
Lenalidomide 2.5mg
Capsule
Celgene Limited
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Celgene International Sarl, Boudry, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Revlimid
Lenalidomide 7.5mg
Capsule
Celgene Limited
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Celgene International Sarl, Boudry, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Revlimid
Lenalidomide 20mg
Capsule
Celgene Limited
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Celgene International Sarl, Boudry, Switzerland

Product:
Component 1:
Active Ingredient:
Dosage Form:
Component 2:
Active Ingredient:
Dosage Form:
Component 3:
Active Ingredient:
Dosage Form:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Trinomia

Aspirin 100mg
Film coated tablet

Atorvastatin calcium trihydrate 21.69mg
Film coated tablet

Ramipril 2.5mg
Film coated tablet
Combination capsule
Te Arai Biofarma Limited
Ferrer International SA, Barcelona, Spain

Product:
Component 1:
Active Ingredient:
Dosage Form:
Component 2:
Active Ingredient:
Dosage Form:
Component 3:
Active Ingredient:
Dosage Form:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Trinomia

Aspirin 100mg
Film coated tablet

Atorvastatin calcium trihydrate 21.69mg
Film coated tablet

Ramipril 5mg
Film coated tablet
Combination capsule
Te Arai Biofarma Limited
Ferrer International SA, Barcelona, Spain

Product:
Component 1:
Active Ingredient:
Dosage Form:
Component 2:
Active Ingredient:
Dosage Form:
Component 3:
Active Ingredient:
Dosage Form:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Trinomia

Aspirin 100mg
Film coated tablet

Atorvastatin calcium trihydrate 21.69mg
Film coated tablet

Ramipril 10mg
Film coated tablet
Combination capsule
Te Arai Biofarma Limited
Ferrer International SA, Barcelona, Spain

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Voriconazole
Voriconazole 50mg
Film coated tablet
Generic Partners (NZ) Limited
Piramal Enterprises Limited, Pithampur, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Voriconazole
Voriconazole 200mg
Film coated tablet
Generic Partners (NZ) Limited
Piramal Enterprises Limited, Pithampur, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Voriconazole
Voriconazole 200mg
Powder for injection
Generic Partners (NZ) Limited
Anfarm Hellas SA, Sximatari Viotias, Greece

Dated this 18th day of April 2017.

ALISON COSSAR, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).